Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment StrategyASAIO JOURNALIF2.32022-02-2713OA
Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?AMERICAN HEART JOURNALIF3.52021-09-011PREAI
Transition of a Large Tertiary Heart Failure Program in Response to the COVID-19 Pandemic Changes That Will Endurejacc heart failureIF8.42020-09-0118PREAI
Use of PCSK9 Inhibitor Therapy in a Small Cohort of Heart Transplant Recipients with Statin Intolerance or Refractory HyperlipidemiaJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62019-04-010PREAI
Home Inotropic Therapy as a Bridge and as Destination: Intended and Unintended Outcomes in a Single Center Contemporary CohortJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62019-04-010PREAI
sCD146-a Novel Marker of Systemic Venous Congestion - Positively Correlates With Plasma Endothelin-1-Marker of Vasoconstriction and Inflammation - in Heart FailureJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62018-04-011PREAI
Revisiting Intravenous Inotropes: Are They as Bad as We Thought in RematchJOURNAL OF CARDIAC FAILUREIF8.22014-08-011PREAI
Leveraging Novel Technologies: Risk Stratification and Care CoordinationJOURNAL OF CARDIAC FAILUREIF8.22013-08-011OA
Successful Initiation of a Mechanical Circulatory Support Program in a Non-Transplant InstitutionJOURNAL OF CARDIAC FAILUREIF8.22011-08-010PREAI
Geriatrics, Emergency Medicine, Primary Care or Cardiology: Who Is the Heart Failure Specialist of the Future?JOURNAL OF CARDIAC FAILUREIF8.22010-08-010PREAI
Association between chronotropic incompetence and endothelial dysfunction in subjects with heart failure receiving chronic β-adrenergic blockadeJOURNAL OF CARDIAC FAILUREIF8.22008-08-010PRE